Virtu KCG Holdings LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu KCG Holdings LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2017$157,000
-42.9%
12,406
-52.6%
0.00%
-50.0%
Q1 2017$275,000
+61.8%
26,160
+42.0%
0.01%
+100.0%
Q4 2016$170,000
-45.9%
18,425
-30.7%
0.00%
-42.9%
Q3 2016$314,000
-50.9%
26,599
-33.5%
0.01%
-61.1%
Q1 2016$640,000
+50.6%
40,022
+238.3%
0.02%
+125.0%
Q2 2015$425,000
+69.3%
11,832
+98.8%
0.01%
+100.0%
Q4 2014$251,000
-46.6%
5,952
-47.7%
0.00%
-33.3%
Q1 2014$470,00011,3710.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2014
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders